Condition
Corticobasal Degeneration (CBD) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Corticobasal Degeneration (CBD) clinical trials that are recruiting, at sites in 3 countries (most in United States (3), China (2), Canada (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Corticobasal Degeneration (CBD) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Natural history of atypical parkinsonian syndromes: a multi-center observation | — | Changshu, Jiangsu and 19 other locations | Recruiting | Sep 8, 2026 |
| Imaging biomarkers in corticobasal syndrome | — | Rochester, Minnesota | Recruiting | Jun 3, 2025 |
| Using AI to improve the levodopa challenge test for Parkinson's disease diagnosis | — | Beijing | Recruiting | Apr 29, 2025 |
| Genetic program for Progressive Supranuclear Palsy and related conditions | — | Boston, Massachusetts | Recruiting | Oct 18, 2024 |
| Longitudinal study of frontotemporal lobar degeneration | — | Birmingham, Alabama and 25 other locations | Recruiting | Apr 27, 2020 |
All recruiting trials (5)
-
Natural history of atypical parkinsonian syndromes: a multi-center observation
This study follows people with APS like MSA, DLB, PSP, and CBD to see how their symptoms and brain images change over time.
-
Imaging biomarkers in corticobasal syndrome
We will use brain imaging and blood tests to see if inflammation is linked to white-matter damage in people with corticobasal syndrome.
-
Using AI to improve the levodopa challenge test for Parkinson's disease diagnosis
This study is testing a new way to diagnose Parkinson's disease using artificial intelligence and video recordings to see if it can improve the accuracy of the levodopa challenge test.
-
Genetic program for Progressive Supranuclear Palsy and related conditions
This study is collecting DNA from adults with Progressive Supranuclear Palsy and similar conditions to see how genetics might help improve diagnosis and care for patients.
-
Longitudinal study of frontotemporal lobar degeneration
This study is trying to learn more about frontotemporal lobar degeneration by following both affected individuals and their family members over time to see how the condition develops.
Related topics
Quick answers
How many Corticobasal Degeneration (CBD) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), China (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.